3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
7
Terminated
4
Active not recruiting
3
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
69
Carcinoma, Non-Small-Cell Lung
62
Stomach Neoplasms
32
Prostatic Neoplasms
21
Nasopharyngeal Carcinoma
20
Lung Neoplasms
20
Squamous Cell Carcinoma of Head and Neck
11
Esophageal Neoplasms
11
Neoplasm Metastasis
8
Head and Neck Neoplasms
7
Inflammatory Breast Neoplasms
6
Pancreatic Neoplasms
5
Neoplasms
5
HER2-positive Breast Cancer
5
Adenocarcinoma
5
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
NSCLC
4
Carcinoma, Squamous Cell
4
Sarcoma
3
Nasopharyngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma, Ovarian Epithelial
3
Breast Diseases
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Tongue Neoplasms
2
Squamous Cell Lung Cancer
2
Interventions
Fluorouracil
80
Oxaliplatin
72
Leucovorin
66
Irinotecan
60
Capecitabine
58
Bevacizumab
57
Cetuximab
43
Folfox protocol
22
Drug Therapy
22
Neoadjuvant Therapy
19
HMPL-013
17
Colonoscopy
17
regorafenib
15
apatinib
11
Panitumumab
11
Chemotherapy, Adjuvant
11
trifluridine tipiracil drug combination
10
XELOX
10
Laparoscopy
10
IFL protocol
10
sintilimab
9
raltitrexed
9
Radiotherapy
9
Blood Specimen Collection
9
Surveys and Questionnaires
8
Surgical Procedures, Operative
8
tislelizumab
7
pembrolizumab
7
Endoscopic Mucosal Resection
7
Aspirin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Colorectal Neoplasms
×
Docetaxel
×
Clear all
NCT02450656
2018-08-27
M14AFS
The Netherlands Cancer Institute
Phase 1/2
Unknown
320 enrolled